www.pharmadeveloppement.com
is the website of PHARMA Développement, a simplified joint-stock company (SAS) with a capital of 120,000 euros, registered with the Trade and Companies Register under number RCS Nevers B 352 563 084 and located at Chemin de Marcy, 58 800 CORBIGNY, 03 86 20 21 64.
The Publisher is Mario GIRON.
The website is hosted by OVH, SAS, 2 Rue Kellermann, 59100 Roubaix. To contact this hosting provider, visit the website at
http://www.ovh.com/fr/support.
The following legal notices detail the terms and conditions that apply to every visitor to this website
www.pharmadeveloppement.com
(hereinafter “the Site”). By accessing the Site, you agree to and are bound by these terms and conditions.
PHARMA Développement reserves the right to modify the content of the Site without prior notice and shall not be held liable for any potential consequences of such changes. Similarly, PHARMA Développement reserves the right to interrupt or suspend all or part of the Site’s functionality at any time and without prior notice.
Information on the Site and Liability
The information provided on the Site by PHARMA Développement is for informational purposes only. It is not intended to replace the advice, treatments, diagnoses, or recommendations provided by healthcare professionals and cannot be considered in any way as medical advice or as guidance on the use of PHARMA Développement products. It cannot, therefore, replace the advice of a healthcare professional, doctor, or pharmacist.
The information contained on this Site is as accurate as possible, and the Site is regularly updated; however, it may contain errors, inaccuracies, or omissions. PHARMA Développement cannot guarantee either the completeness or the accuracy of any information provided.
With the exception of direct damages resulting from willful or gross negligence on the part of PHARMA Développement, PHARMA Développement disclaims all liability for any direct or indirect damages, whether serious or not, that may result from the visitor’s use of the Site and/or the visitor’s use of the information contained therein. The same applies to any harm resulting from a fraudulent intrusion by a third party onto the Site that may have distorted the information contained therein.
Intellectual Property
The content of this Site is protected by the laws and regulations governing copyright and literary and artistic property rights.
The Site may publish various expert opinions or the content of articles appearing in the specialized press. The content of these articles or expert opinions reflects only the views of their authors; they are expressions of personal opinion and do not bind PHARMA Développement should they prove to be inaccurate or incomplete.
All text, illustrations, logos, and photographs contained on this Site are the property of PHARMA Développement, with the exception of trademarks, logos, or content belonging to other partner companies or authors. Any reproduction, distribution, modification, adaptation, retransmission, or publication—even partial—of these various elements is strictly prohibited without the written consent of PHARMA Développement.
Such representation or reproduction, by any means whatsoever, constitutes an infringement punishable under Articles L.335-2 et seq. of the Intellectual Property Code. Failure to comply with this prohibition constitutes an infringement that may result in civil and criminal liability for the infringer. Furthermore, the owners of the copied Content may take legal action against you.
Territorial Scope
The website www.pharmadeveloppement.com
was designed to provide institutional information about PHARMA développement in France.
The website www.pharmadeveloppement.com
and its content are subject to French law, including with respect to jurisdictional authority. Since PHARMA Développement has its headquarters in France, the information contained on this website complies with the legal provisions applicable in France. As regulations in other countries and medical practices may differ, this information may prove inappropriate outside of France.
PHARMA Développement designed and developed the Site in accordance with the criteria of the “Charter for the Communication and Promotion of Health Products (Medicines and Medical Devices) on the Internet and in E-Media,” updated in March 2014.
Data Processing
Personal Data
PHARMA Développement will not disclose to third parties any personal data that may be provided through the Site’s “Contact” page or via email. Such data will be used solely for the purpose of responding to users as effectively as possible.
In accordance with “Law No. 2004-801 of August 6, 2004, the Act on the Protection of Individuals with Regard to the Processing of Personal Data and amending Act No. 78-17 of January 6, 1978, on Information Technology, Files, and Civil Liberties,” visitors have the right to access, modify, correct, and delete personal data concerning them. To do so, simply submit a request online at:
contact@pharmadeveloppement.com
Use of Cookies
In order to evaluate, improve, and develop its website, PHARMA Développement uses the Google Analytics web analytics service. This tool primarily uses first-party cookies, which are text files placed on the user’s computer to generate reports on visitors’ interactions with the PHARMA Développement website. Pseudonymized user profiles are created, and cookies are used for this purpose. The data collected during the analysis includes:
- Browser type and version
- The operating system used
- Activities performed on the PHARMA Développement website
- A portion of the IP address
- The time the analysis was performed
The IP address is partially recorded to prevent the precise location of visitors from being identified (IP address masking). Google cannot associate it with any other data it may hold. During the analysis, no personally identifiable information is provided. The collected data is retained for a period of 14 months. After that, it is deleted.
For more information, visitors can consult the Google page
“How do we use the information collected through websites or apps that use our services?”.
The collected data can be deleted. To do so, simply submit a request online at:
contact@pharmadeveloppement.com.
Additional information is available in the
“Privacy Policy“ provided by Google.
Hyperlinks
The www.pharmadeveloppement.com website
may contain hyperlinks or references to other websites. PHARMA Développement has no control over the content of third-party websites and cannot be held liable for any direct or indirect damages resulting from viewing such content. Any link to another website is provided solely for the convenience of users of this Site.
PHARMA Développement expressly authorizes the reproduction of the hyperlink to the homepage of the site
www.pharmadeveloppement.com.
Any other hyperlink is the exclusive property of PHARMA Développement and must be authorized in advance by the company. Any request for such prior authorization must be sent to the following address:
contact@pharmadeveloppement.com
Overall Professional Equality Index for 2026 based on 2025 data.
The Overall Professional Equality Index is a score out of 100, calculated annually based on 4 or 5 indicators, depending on the size of the company.
- Pay Gap Indicator: 37/40
- Individual Pay Increase Rate Gap Indicator: 35 out of 35
- Maternity Leave Return Indicator: cannot be calculated
- High-Pay Indicator: 10 out of 10
Our company’s score is 96 out of 100. The gap favors women.
Last update of the Terms and Conditions of Use: February 27, 2026